Sodium Cromoglycate and Nedocromil Sodium

  • Alan M. Edwards
  • Alexis E. Harper
  • D. Ken Rainey
  • Alan A. Norris


The major allergic diseases are all inflammatory diseases of body surfaces, namely the bronchial mucosa, the nasal mucosa, the conjunctiva, the skin, and the gastrointestinal mucosa. The pathological changes and inflammatory mechanisms in allergic disease are common to the different tissues, involving tissue damage, tissue restructure, and the presence of activated inflammatory cells, particularly eosinophils, mast cells, lymphocytes, and macrophages.


Mast Cell Allergy Clin Immunol Sodium Cromoglycate Human Bronchial Epithelial Cell Nedocromil Sodium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dunnil MS (1960) The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 13: 27–33.CrossRefGoogle Scholar
  2. 2.
    Beasley R, Roche WR, Roberts JA, Holgate ST (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139: 806–817.PubMedGoogle Scholar
  3. 3.
    Djukanovic R, Lai CKW, Wilson JW, Britten KM, Wilson SJ, Roche WR, Howarth PH, Holgate ST (1992) Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy control. Eur Respir J 5: 538–544.PubMedGoogle Scholar
  4. 4.
    Pepys J (1973) Disodium cromoglycate in clinical and experimental asthma. In: Austen KF, Lichtenstein CM, eds. Asthma: Physiology, Immunopharmacology and Treatment Academic, London, Press, pp. 279–294.Google Scholar
  5. 5.
    Montefort S, Gratizou C, Goulding D, Polosa R, Haskard DO, Howarth PH, Holgate ST, Carroll MP (1994) Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitised asthmatic airways. J Clin Invest 93: 1411–1421.PubMedCrossRefGoogle Scholar
  6. 6.
    Cockcroft DW, Murdock KY (1987) Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol, 79: 734–740.PubMedCrossRefGoogle Scholar
  7. 7.
    Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425–434.PubMedCrossRefGoogle Scholar
  8. 8.
    Gordon JR, Galli SJ (1991) Release of both preformed and newly synthesised tumour necrosis factor-a (TNFa)/cachetin by mouse mast cells stimulated with FcER1. A mechanism for sustained action of mast cell derived TNFa during IgE-dependent biological responses. J Exp Med 174: 103–107.Google Scholar
  9. 9.
    Liu MC, Bleecker ER, Lichtenstein LM, Kagey-Sobotka A, Nic Y, McLemore TL, Permutt S, Proud D, Hubbard WC (1990) Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 142: 126–132.PubMedGoogle Scholar
  10. 10.
    Riley PA, Mather ME, Keogh RW, Eady RP (1987) Activity of nedocromil sodium in mast-celldependent reactions in the rat. Int Arch Allergy Appl Immunol 82: 108–110.PubMedCrossRefGoogle Scholar
  11. 11.
    Wells E, Jackson CG, Harper ST, Mann J, Eady RP (1986) Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4 and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol 137: 3941–3945.PubMedGoogle Scholar
  12. 12.
    Leung KBP, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Lau HYA, Liu WL, Pearce FL (1988) Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 43: 756–761.PubMedCrossRefGoogle Scholar
  13. 13.
    Bissonnette EY, Enciso JA, Befus AD (1995) Interferon and antiallergic regulation of histamine and tumour necrosis factor-alpha in rat mast cell subsets. Int Arch Allergy Immunol 107: 156–157.PubMedCrossRefGoogle Scholar
  14. 14.
    Bissonnette EY, Befus AD (1993) Modulation of mast cell function in the gastrointestinal tract. In: Willace JL, The Handbook of Immunopharmacology: Immunopharmacology of the Gastrointestinal System, Academic, London, pp. 95–103.Google Scholar
  15. 15.
    Hoshino M, Nakamura Y (1995) The effect of disodium cromoglycate on infiltration of inflammatory cells into bronchial mucosa and on expression of adhesion molecules in asthmatics. Jpn J Allergol 44: 593–601.Google Scholar
  16. 16.
    Manolitsas ND, Wang J, Devalia IL, Trigg CJ, McAulay AE, Davies RJ (1995) Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med 151: 1925–1930.PubMedGoogle Scholar
  17. 17.
    Rand TH, Lopez AF, Gamble JR, Vadas MA (1988) Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity. Int Arch Allergy Appl Immunol 87: 151–158.PubMedCrossRefGoogle Scholar
  18. 18.
    Moqbel R, Cromwell O, Walsh GM, Wardlaw AJ, Kurlak L, Kay AB (1988) Effects of nedocromil sodium ( Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy 43: 268–276.Google Scholar
  19. 19.
    Bruijnzeel PLB, Warringa RAJ, Kok PTM (1989) Inhibition of platelet-activating factor-and zymosanactivated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Br J Pharmacol 97: 1251–1257.PubMedCrossRefGoogle Scholar
  20. 20.
    Bruijnzeel PLB, Warringa RAJ, Kok PTM, Kreukniet J (1990) Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate. Br J Pharmacol 99: 798–802.PubMedCrossRefGoogle Scholar
  21. 21.
    Devalia JL, Rusznak C, Abdelaziz MM, Davies RJ (1996) Nedocromil sodium and airway inflammation in vivo and in vitro. J Allergy Clin Immunol 98: S51–57.PubMedCrossRefGoogle Scholar
  22. 22.
    Marini M, Soloperto M, Zheng Y, Mezzetti M, Mattoli S (1992) Protective effect of nedocromil sodium on the IL1-induced release of GM-CSF from cultured human bronchial epithelial cells. Pulmonary Pharmacol 5: 61–65.CrossRefGoogle Scholar
  23. 23.
    Vittori E, Sciacca F, Colotta F, Mantovani A, Mattoli S (1992) Protective effect of nedocromil sodium on the interleukin-l-induced production of interleukin-8 in human bronchial epithelial cells. J Allergy Clin Immunol 90: 76–84.PubMedCrossRefGoogle Scholar
  24. 24.
    Vignola AM, Chanez P, Lacoste P, Campbell AM, Norris A, Michel FB, Bousquet J, Godard P (1993) Nedocromil modulates the histamine induced expression of ICAM-1 and HLA DR molecules on bronchial epithelial cells. Am Rev Respir Dis 147 (4): A45.Google Scholar
  25. 25.
    Borish L, Williams J, Johnson S, Mascali JJ, Miller R, Rosenwasser LJ (1992) Anti-inflammatory effects of nedocromil sodium: inhibition of alveolar macrophage function. Clin Exp Allergy 22: 984–990.PubMedCrossRefGoogle Scholar
  26. 26.
    Thorel T, Joseph M, Vorng H, Capron A (1988) Regulation of IgE-dependent antiparasite functions of rat macrophages and platelets by nedocromil sodium. Int Arch Allergy Appl Immunol 85: 227–231.PubMedCrossRefGoogle Scholar
  27. 27.
    Tsicopoulos A, Lassalle P, Joseph M, Tonnell AB, Thorel T, Dessaint JP, Capron A (1988) Effect of dis-odium cromoglycate on the inflammatory cells bearing the Fc epilson receptor Type II (FcERII). Int J Immunopharmacol 10: 227–236.PubMedCrossRefGoogle Scholar
  28. 28.
    Loh RKS, Jabara HH, Geha RS (1994) Disodium cromoglycate inhibits Sµ to Se deletional switch recombination and IgE synthesis in human B cells. J Exp Med 180: 663–671.PubMedCrossRefGoogle Scholar
  29. 29.
    Kimata H, Yoshida A, Ishioka C, Mikawa H (1991) Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin Exp Immunol 84: 395–399.Google Scholar
  30. 30.
    Loh RKS, Jabara HH, Geha RF (1996) Mechanisms of inhibition of IgE synthesis by nedocromil sodium: nedocromil sodium inhibits deletional switch recombination in human B cells. J Allergy Clin Immunol 97: 1141–1150.PubMedCrossRefGoogle Scholar
  31. 31.
    Kimata H, Hiratsuka S (1994) Effect of topical sodium cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide. Eur J Pediatr 153: 66–71.PubMedCrossRefGoogle Scholar
  32. 32.
    Diaz P, Galleguillos FR, Cristina Gonzalez M, Pantin CFA, Kay AB (1984) Bronchoalveolar lavage in asthma: The effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 74: 41–48.Google Scholar
  33. 33.
    Marquette CH, Joseph M, Tonnel AB, Vorng H, Lassalle P, Tsicopoulos A, Capron A, Tsicopoulos A, Capron A (1990) The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate. Br J Clin Pharmacol 29: 525–531.PubMedCrossRefGoogle Scholar
  34. 34.
    Roth M, Soler M, Lefkowitz H, Chem I, Emmons LR, Anstine D, Hornung M, Perruchoud AP (1993) Inhibition of receptor-mediated platelet activation by nedocromil sodium. J Allergy Clin Immunol 91: 1217–1225.PubMedCrossRefGoogle Scholar
  35. 35.
    O’Hehir RE, Moqbel R (1989) Action of nedocromil sodium and sodium cromoglycate on cloned human allergen-specific CD4+ T lymphocytes. Drugs 37 (Suppl 1): 23–25.PubMedCrossRefGoogle Scholar
  36. 36.
    Dixon M, Jackson DM, Richards IM (1980) The action of sodium cromoglycate on `C’ fibre endings in the dog lung. Br J Pharmacol 70: 11–13.PubMedCrossRefGoogle Scholar
  37. 37.
    Hargreaves MR, Benson MK (1995) Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 45: 13–16.CrossRefGoogle Scholar
  38. 38.
    Jackson DM, Norris AA, Eady RP (1989) Nedocromil sodium and sensory nerves in the dog lung. Pulmonary Pharmacol 2: 179–184.CrossRefGoogle Scholar
  39. 39.
    Louis RE, Radermecker MF (1990) Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline. Int Arch Allergy Appl Immunol 92: 329–333.PubMedCrossRefGoogle Scholar
  40. 40.
    Armour CL, Johnson PRA, Black JL (1991) Nedocromil sodium inhibits substance P-induced potentiation of cholinergic neural responses in the isolated innervated rabbit trachea. J Auton Pharmacol 11: 167–172.PubMedCrossRefGoogle Scholar
  41. 41.
    Verleden GM, Belvisi MG, Stretton CD, Barnes PJ (1991) Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. Am Rev Respir Dis 143: 114–118.PubMedGoogle Scholar
  42. 42.
    Abraham WM, Sielczak MW, Wanner A, Perruchoud AP, Blinder L, Stevenson JS, Ahmed A, Yerger LD (1988) Cellular markers of inflammation in the airways of allergic sheep with and without allergen-induced late responses. Am Rev Respir Dis 138: 1565–1571.PubMedGoogle Scholar
  43. 43.
    Pretolani M, Lefort J, Silva P, Malanchere E, Dumarey C, Bachelet M, Vargaftig BB (1990) Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig. Am Rev Respir Dis 141: 1259–1265.PubMedGoogle Scholar
  44. 44.
    Hutson PA, Holgate ST, Church MK (1988) Inhibition by nedocromil sodium of early and late phase bronchoconstriction and airway cellular infiltration provoked by ovalbumin inhalation in conscious sensitized guinea-pigs. Br J Pharmacol 94: 6–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Jackson DM, Eady RP (1988) Acute transient S02-induced airway hyperreactivity: effects of nedocromil sodium. J Appl Physiol 65: 1119–1124.PubMedGoogle Scholar
  46. 46.
    Abraham WM, Stevenson JS, Chapman GA, Tallent MW, Jackowski J (1987) The effect of nedocromil sodium and cromolyn sodium on antigen-induced responses in allergic sheep in vivo and in vitro. Chest 92: 913–917.PubMedCrossRefGoogle Scholar
  47. 47.
    Eady RP, Greenwood B, Jackson DM, On TSC, Wells E (1985) The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey. Br J Pharmacol 85: 323–325.Google Scholar
  48. 48.
    Hutson PA, Holgate ST, Church MK (1988) The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of non-anesthetized guinea pigs. Am Rev Respir Dis 138: 1157–1163.PubMedGoogle Scholar
  49. 49.
    Jackson DM (1988) The effect of nedocromil sodium, sodium cromoglycate and codeine phosphate on citric acid-induced cough in dogs. Br J Pharmacol 93: 609–612.PubMedCrossRefGoogle Scholar
  50. 50.
    Norris AA, Alton EWFW (1996) Chloride transport and the action of sodium cromoglycate and nedocromil sodium in asthma. Clin Exp Allergy 26: 250–253.PubMedCrossRefGoogle Scholar
  51. 51.
    Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC (1984) The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 259: 129–136.Google Scholar
  52. 52.
    Penner R, Matthews G, Neher E (1988) Regulation of calcium influx by second messengers in rat mast cells. Nature 334: 499–504.PubMedCrossRefGoogle Scholar
  53. 53.
    Alton EWFW, Kingsleigh-Smith DJ, Munkonge FM, Smith SN, Lindsay ARG, Gruenert DC, Jeffery PK, Norris AA, Geddes DM, Williams AJ (1996) Asthma prophylaxis agents alter the function of an airway epithelial chloride channel. Am J Respir Cell Mol Biol 14: 380–387.PubMedGoogle Scholar
  54. 54.
    Heinke S, Szucs G, Norris A, Droogmans G, Nilius B (1995) Inhibition of volume-activated chloride currents in endothelial cells by chromones. Br J Pharmacol 115: 1393–1398.PubMedCrossRefGoogle Scholar
  55. 55.
    Jackson DM, Pollard CE, Roberts SM (1992) The effect of nedocromil sodium on the isolated rabbit vagus nerve. Eur J Pharmacol 221: 175–177.PubMedCrossRefGoogle Scholar
  56. 56.
    Foreman JC, Hallet MB, Mongar JL (1977) Site of action of the antiallergic drugs cromoglycate and doxantrazole. Br J Pharmacol 59: 473 P.Google Scholar
  57. 57.
    Theoharides TC, Sieghart W, Greengard P, Douglas WW (1980) Antiallergic drug cromolyn may inhibit secretion by regulating phosphorylation of a mast cell protein. Science 207: 80–82.PubMedCrossRefGoogle Scholar
  58. 58.
    Wells E, Mann J (1983) Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds. Biochem Pharmacol 32: 837–842.PubMedCrossRefGoogle Scholar
  59. 59.
    Mackay G, Pearce F (1993) Extracellular cGMP has a spectrum of activity in rodent isolated mast cells similar to that of sodium cromoglycate. Br J Pharmacol 109: 65 P.Google Scholar
  60. 60.
    National Institutes of Health (NIH), NHLBI (1995) Global Strategy for Asthma Management and Prevention. National Heart, Lung, and Blood Institute (NHLBI)/World Health Organization (WHO) Workshop Report, March 1993. Publication no. 95–3659, National Institutes of Health, Bethesda, MD.Google Scholar
  61. 61.
    National Heart, Lung, and Blood Institute, National Institutes of Health (1992) International Consensus Report on Diagnosis and Treatment of Asthma. Publication no. 92–3091, National Institutes of Health, Bethesda, MD.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Alan M. Edwards
  • Alexis E. Harper
  • D. Ken Rainey
  • Alan A. Norris

There are no affiliations available

Personalised recommendations